...
blac-img

Bellevue Life Sciences Acquisition Corp. Common Stock, Common Stock

BLAC

NAQ

$11.2699

+$0.01

(0.09%)

1D
Industry: Capital Markets Sector: Financials

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$45.75M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.07K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$10.47 L
$13.4 H
$11.2699

About Bellevue Life Sciences Acquisition Corp. Common Stock, Common Stock

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. more

Industry: Capital MarketsSector: Financials

Returns

Time FrameBLACSectorS&P500
1-Week Return-0.44%-3.51%-3%
1-Month Return-2.85%-3.51%-0.73%
3-Month Return3.49%4.69%2.87%
6-Month Return4.84%15.21%7.17%
1-Year Return7.64%29.54%25.31%
3-Year Return11.58%26.93%28.38%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses23.81K3.31K35.39K1.83M[{"date":"2020-12-31","value":1.3,"profit":true},{"date":"2021-12-31","value":0.18,"profit":true},{"date":"2022-12-31","value":1.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(23.81K)(3.31K)(35.39K)(1.83M)[{"date":"2020-12-31","value":-2381000,"profit":false},{"date":"2021-12-31","value":-330800,"profit":false},{"date":"2022-12-31","value":-3538800,"profit":false},{"date":"2023-12-31","value":-183070000,"profit":false}]
Total Non-Operating Income/Expense--2.005.55M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(23.81K)(3.31K)(35.39K)944.59K[{"date":"2020-12-31","value":-2.52,"profit":false},{"date":"2021-12-31","value":-0.35,"profit":false},{"date":"2022-12-31","value":-3.75,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(206.30K)(236.56K)(228.48K)540.81K[{"date":"2020-12-31","value":-38.15,"profit":false},{"date":"2021-12-31","value":-43.74,"profit":false},{"date":"2022-12-31","value":-42.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes--193.09K403.78K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":47.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations-(3.31K)(35.39K)403.78K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":-8.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(23.81K)(3.31K)(35.39K)403.78K[{"date":"2020-12-31","value":-5.9,"profit":false},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":-8.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)---0.04[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BLAC
Cash Ratio 0.00
Current Ratio 0.01

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BLAC
ROA (LTM) -2.98%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BLAC
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BLAC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.05
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Bellevue Life Sciences Acquisition Corp. Common Stock share price today?

Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) share price today is $11.2699

Can Indians buy Bellevue Life Sciences Acquisition Corp. Common Stock shares?

Yes, Indians can buy shares of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) on Vested. To buy Bellevue Life Sciences Acquisition Corp. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BLAC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bellevue Life Sciences Acquisition Corp. Common Stock be purchased?

Yes, you can purchase fractional shares of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) via the Vested app. You can start investing in Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) with a minimum investment of $1.

How to invest in Bellevue Life Sciences Acquisition Corp. Common Stock shares from India?

You can invest in shares of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) via Vested in three simple steps:

  • Click on Sign Up or Invest in BLAC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bellevue Life Sciences Acquisition Corp. Common Stock shares
What is Bellevue Life Sciences Acquisition Corp. Common Stock 52-week high and low stock price?

The 52-week high price of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is $13.4. The 52-week low price of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is $10.47.

What is Bellevue Life Sciences Acquisition Corp. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is

What is Bellevue Life Sciences Acquisition Corp. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is 3.05

What is Bellevue Life Sciences Acquisition Corp. Common Stock dividend yield?

The dividend yield of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is 0.00%

What is the Market Cap of Bellevue Life Sciences Acquisition Corp. Common Stock?

The market capitalization of Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) is $45.75M

What is Bellevue Life Sciences Acquisition Corp. Common Stock’s stock symbol?

The stock symbol (or ticker) of Bellevue Life Sciences Acquisition Corp. Common Stock is BLAC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top